eli lilly sues four telehealth compounding glp-1 companies sued firms, but it is adopting a new legal strategy in its fight against compounded GLP-1s GLP-1 Update: Novo Nordisk Sues

The immune system will then produce excessive inflammatory chemicals and in some cases, auto-antibodies because it is in a hyper-stimulated state

Pharmaceutics 14(6):1213

In diabetes care, adherence is often driven by necessity

Most online GLP-1 providers do not accept CareCredit

Earlier-stage assets broaden the pipeline: AMX0035 showed encouraging Phase 2 data in Wolfram syndrome, AMX0114 completed two Phase 1 cohorts in ALS with no treatment-related serious adverse events, and AMX0318 advanced into IND-enabling work as a long-acting GLP1 receptor antagonist

Xu C, Chen YP, and Du XJ, et al (2018) Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis BMJ 363 k4226 PMID: 30409774 PMCID: 6222274 43